Nature Biotechnology, Published online: 10 June 2025; doi:10.1038/s41587-025-02708-7
The first cancer vaccines matched to a person’s unique tumor neoantigens are forging ahead, with expectations running high as the field awaits results from the first pivotal trial.
Nature Biotechnology, Published online: 10 June 2025; doi:10.1038/s41587-025-02708-7The first cancer vaccines matched to a person’s unique tumor neoantigens are forging ahead, with expectations running high as the field awaits results from the first pivotal trial. Read More
